Job Trends
Labor Market Reports
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second quarter of 2025, with increased pressure from further layoffs.
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
Now Hiring
Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.
Looking for a biopharma job in New York? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
Career Advice
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
THE LATEST
It was a moderately busy week for clinical trial news. Here’s a look.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
APEX Biologix, a nationally recognized leader in manufacturing and distributing cutting-edge biologic supplies will now have access to an exciting new product.
Scientists have known for decades that electrical stimulation promotes healing of chronic wounds, such as diabetic ulcers and bedsores, but how it happens has been a mystery
According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.
Last week was an unusually busy week for clinical trial news, with numerous companies presenting results at conferences. Here’s a look at the top stories.
AveXis presented new interim data from the Phase III SPR1NT trial of Zolgensma (onasemnogene abeparvovec-xioi) in spinal muscular atrophy (SMA) Type 1.
Nation’s largest public health plan with nearly 2.2 million members taps Ntooitive to drive brand awareness, leveraging agency’s new marketing solution called Ntooitive Healthcare
Pulmotect, Inc., a clinical-stage biotechnology company developing an inhaled immunomodulatory agent, is pleased to announce the appointment of Dr. Kumar Srinivasan to its Board of Directors.
A University of Houston chemist is exploring the link between copper protein molecules in brain cells and their link to neurodegenerative diseases like Alzheimer’s.